NCT07510828: PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 60 planned
- Started
- 2 Mar 2026
- Primary completion
- 14 Mar 2027
- Arms
- Arm A: Single-target precision-matched CAR-NK, Arm B: Dual-target precision-matched CAR-NK
- Results
- None posted
- 2 Mar 2026: Trial started
- 6 Apr 2026: Trial registered